MHCAG's most productive year in 2023 through publications on medication treatment for adults with GAD, antipsychotic medication algorithms for schizophrenia, and more. Plus, discover the group's increased consultations with the P&T Committee. Look ahead to 2024 with potential topics and planned revi

2 views • 4 slides

Antipsychotic drugs, also known as neuroleptics, are essential in treating schizophrenia and other psychotic disorders. They work by targeting dopamine and serotonin receptors in the brain, managing symptoms like hallucinations and delusions. Learn about the dopamine-serotonin hypothesis of schizoph

9 views • 21 slides

Antipsychotic drugs play a vital role in managing psychotic disorders by targeting dopamine and serotonin receptors. This overview covers the mechanism of action, classification (typical vs. atypical), side effects, and therapeutic efficacy of antipsychotic medications. It also delves into the mood-

0 views • 31 slides

Dive into the investigation by Naomi Jessurun, PharmD, exploring whether norclozapine is responsible for body weight gain in patients treated with clozapine. The research delves into the impact of drug metabolization and metabolites on adverse reactions, shedding light on the complexities surroundin

0 views • 43 slides

The data showcases quarterly performance percentiles and quality measures in Oklahoma healthcare facilities, highlighting changes in anti-psychotic medication, pressure ulcers, urinary tract infections, and excess weight loss. Furthermore, program audit outcomes reveal common trends such as high tur

0 views • 4 slides

The performance measure assessed the use of first-line psychosocial care for children and adolescents on antipsychotics in Virginia, showing a total measure result of 68.98%. The measure aims to promote safer interventions before prescribing antipsychotic medications to minimize risks. Results were

0 views • 25 slides